Literature DB >> 19563777

Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels.

Linlin Zhong1, Ziwen Liu, Ruilan Yan, Stephen Johnson, Yupei Zhao, Xiubin Fang, Deliang Cao.   

Abstract

Alpha, beta-unsaturated carbonyls are highly reactive mutagens and carcinogens to which humans are exposed on a daily basis. This study demonstrates that aldo-keto reductase family 1 member B10 (AKR1B10) is a critical protein in detoxifying dietary and lipid-derived unsaturated carbonyls. Purified AKR1B10 recombinant protein efficiently catalyzed the reduction to less toxic alcohol forms of crotonaldehyde at 0.90 microM, 4-hydroxynonenal (HNE) at 0.10 microM, trans-2-hexanal at 0.10 microM, and trans-2,4-hexadienal at 0.05 microM, the concentrations at or lower than physiological exposures. Ectopically expressed AKR1B10 in 293T cells eliminated immediately HNE at 1 (subtoxic) or 5 microM (toxic) by converting to 1,4-dihydroxynonene, protecting the cells from HNE toxicity. AKR1B10 protein also showed strong enzymatic activity toward glutathione-conjugated carbonyls. Taken together, our study results suggest that AKR1B10 specifically expressed in the intestine is physiologically important in protecting the host cell against dietary and lipid-derived cytotoxic carbonyls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563777      PMCID: PMC2756731          DOI: 10.1016/j.bbrc.2009.06.123

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism.

Authors:  V Vasiliou; A Pappa; D R Petersen
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

2.  Structural basis of protein-bound endogenous aldehydes. Chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct.

Authors:  Mika Hashimoto; Takahiro Sibata; Hiroaki Wasada; Shinya Toyokuni; Koji Uchida
Journal:  J Biol Chem       Date:  2002-12-06       Impact factor: 5.157

3.  Overexpression of aldose reductase in liver cancers may contribute to drug resistance.

Authors:  K W Lee; B C Ko; Z Jiang; D Cao; S S Chung
Journal:  Anticancer Drugs       Date:  2001-02       Impact factor: 2.248

4.  Development of a 32P-postlabelling method for the detection of 1,N2-propanodeoxyguanosine adducts of crotonaldehyde in vivo.

Authors:  B D Schuler; E Eder
Journal:  Arch Toxicol       Date:  2000-09       Impact factor: 5.153

5.  Possible mutagens derived from lipids and lipid precursors.

Authors:  H Esterbauer; P Eckl; A Ortner
Journal:  Mutat Res       Date:  1990-05       Impact factor: 2.433

6.  Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.

Authors:  Amy M Quinn; Ronald G Harvey; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2008-11       Impact factor: 3.739

Review 7.  Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?

Authors:  Brian F Coles; Fred F Kadlubar
Journal:  Biofactors       Date:  2003       Impact factor: 6.113

8.  Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels.

Authors:  F Xavier Ruiz; Oriol Gallego; Albert Ardèvol; Armando Moro; Marta Domínguez; Susana Alvarez; Rosana Alvarez; Angel R de Lera; Carme Rovira; Ignacio Fita; Xavier Parés; Jaume Farrés
Journal:  Chem Biol Interact       Date:  2008-10-25       Impact factor: 5.192

Review 9.  Endogenous DNA damage in humans: a review of quantitative data.

Authors:  Rinne De Bont; Nik van Larebeke
Journal:  Mutagenesis       Date:  2004-05       Impact factor: 3.000

Review 10.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases.

Authors:  B N Ames
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

View more
  31 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Protein carbonylation and metabolic control systems.

Authors:  Jessica M Curtis; Wendy S Hahn; Eric K Long; Joel S Burrill; Edgar A Arriaga; David A Bernlohr
Journal:  Trends Endocrinol Metab       Date:  2012-06-27       Impact factor: 12.015

3.  AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells.

Authors:  Chenfei Huang; Zhe Cao; Jun Ma; Yi Shen; Yiwen Bu; Ramina Khoshaba; Guiyuan Shi; Dan Huang; Duan-Fang Liao; Haitao Ji; Junfei Jin; Deliang Cao
Journal:  Mol Carcinog       Date:  2018-06-28       Impact factor: 4.784

4.  Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.

Authors:  Zhenwang Tang; Chenglai Xia; Renbin Huang; Xiaoning Li; Wan-Chun Wang; Wangyuan Guo; Lili Duan; Weihao Luo; Deliang Cao; Di-Xian Luo
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Dietary regulation of catabolic disposal of 4-hydroxynonenal analogs in rat liver.

Authors:  Qingling Li; Kristyen Tomcik; Shenghui Zhang; Michelle A Puchowicz; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2012-01-04       Impact factor: 7.376

Review 6.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

7.  AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.

Authors:  Linlin Zhong; Honglin Shen; Chenfei Huang; Hongwu Jing; Deliang Cao
Journal:  Toxicol Appl Pharmacol       Date:  2011-05-26       Impact factor: 4.219

8.  Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.

Authors:  Fanhong Zeng; Yue Zhang; Xu Han; Min Zeng; Yi Gao; Jun Weng
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

9.  Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis.

Authors:  Yongzhen Liu; Jing Zhang; Hui Liu; Guiwen Guan; Ting Zhang; Leijie Wang; Xuewei Qi; Huiling Zheng; Chia-Chen Chen; Jia Liu; Deliang Cao; Fengmin Lu; Xiangmei Chen
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

10.  Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.

Authors:  Dixian Luo; Yiwen Bu; Jun Ma; Sandeep Rajput; Yingchun He; Guangxian Cai; Duan-Fang Liao; Deliang Cao
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.